Health
Medical
Banking

Global Cord Blood

$7.06
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.09 (-1.26%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell CO and other stocks, options, ETFs, and crypto commission-free!

About

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies such as cord blood transplants. Read More The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. It preserves cord blood units donated by the public and provide matching services on such donated units and deliver matching units to patients in need of transplants. Global Cord Blood was founded on January 17, 2008 and is headquartered in Hong Kong.

Employees
1,196
Headquarters
Hong Kong, Central & Western
Founded
2008
Market Cap
869.09M
Price-Earnings Ratio
24.60
Dividend Yield
0.00
Average Volume
147.07K
High Today
$7.08
Low Today
$6.90
Open Price
$7.03
Volume
14.54K
52 Week High
$11.62
52 Week Low
$5.67

Collections

Health
Medical
Banking
Finance
China
Asia
Female CEOs

News

Markets InsiderFeb 25

Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2019

3Q19 Added 23,663 New Subscribers Revenues Up 3.7% YoY to RMB254.2 Million ($37.0 Million) Operating Income Increased to RMB92.6 Million ($13.5 Million) Conference Call to be Held on February 26, 2019 at 8:00 a.m. ET HONG KONG, Feb. 26, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its unaudited financial resu...

67
PR NewswireFeb 19

Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2019 Financial Results

HONG KONG, Feb. 19, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release its unaudited financial results for the third quarter and first nine months of fiscal year 2019 on Monday, February 25, 2019, after the market close. The Company will host a conference call at 8:00 a.m. ET on Tuesday, February 26, 20...

0

Earnings

$0.00
$0.04
$0.09
$0.13
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
Actual
Expected Jun 26, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.